Objective:To analyze the effect of Pioglitazone combined with cyproterone acetate on the reproductive hormone level and insulin resistance of patients with polycystic ovary syndrome. Methods: 96 patients with the polycystic ovary syndrome in our hospital were randomly divided into observation group and controlgroup two groups, each of 48 cases. The control group was treated with the treatment of cyproterone acetate, observation group was treated with pioglitazone combined with cyproterone acetate treatment. The clinical efficacy of two groups were compared. The serum follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), testosterone (T) and fasting plasma glucose (FBG), fasting insulin (FINS) level before and after treatment and calculate the insulin resistance index (IR) were observed. Results: After treatment, serum FSH, LH and T levels of two groups were significantly lower than that before treatment (P0.05). FBG, FINS and IR of the patients in the observation group were significantly lower than the control group (P<0.05).Conclusion:pioglitazone combined with cyproterone acetate has significant therapeutic effect on polycystic ovary syndrome, can effectively improve the patients with insulin resistance and reproductive hormone disorder.
展开▼
